These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3040247)
1. Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial. Drasga RE; Williams SD; Einhorn LH; Birch R Cancer Treat Rep; 1987 Sep; 71(9):863-4. PubMed ID: 3040247 [No Abstract] [Full Text] [Related]
2. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group. Williams SD; Birch R; Gams R; Irwin L Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593 [No Abstract] [Full Text] [Related]
3. Phase II trial of 1,2-diaminocyclohexane-(4-carboxyphthalato) platinum(II) in patients with refractory germ cell tumors. Chun H; Bosl GJ; Golbey RB Cancer Treat Rep; 1985 Apr; 69(4):459-60. PubMed ID: 2986834 [No Abstract] [Full Text] [Related]
4. Phase II trial of carboplatin in patients with advanced germ cell tumors refractory to cisplatin. Motzer RJ; Bosl GJ; Tauer K; Golbey R Cancer Treat Rep; 1987 Feb; 71(2):197-8. PubMed ID: 3026627 [TBL] [Abstract][Full Text] [Related]
5. Growth and chemotherapy of a human germ-cell tumour line (GCT 27). Schlappack OK; Bush C; Delic JI; Steel GG Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535 [No Abstract] [Full Text] [Related]
6. Phase II study of oral medroxyprogesterone acetate in advanced germ cell tumors. Cavalli F; Klepp O; Hansen H; Rozencweig M Cancer Treat Rep; 1983 Oct; 67(10):953-4. PubMed ID: 6313188 [No Abstract] [Full Text] [Related]
7. Carboplatin in advanced, refractory germ cell neoplasms: a phase II Eastern Cooperative Oncology Group Study. Trump DL; Elson P; Brodovsky H; Vogl SE Cancer Treat Rep; 1987 Oct; 71(10):989-90. PubMed ID: 2820572 [No Abstract] [Full Text] [Related]
8. Phase II trial of mitoguazone in patients with refractory germ cell tumors. Chun H; Bosl GJ Cancer Treat Rep; 1985 Apr; 69(4):461-2. PubMed ID: 2986835 [No Abstract] [Full Text] [Related]
10. Phase II trial of 13-cis-retinoic acid in patients with advanced nonseminomatous germ cell tumors. Gold EJ; Bosl GJ; Itri LM Cancer Treat Rep; 1984 Oct; 68(10):1287-8. PubMed ID: 6098365 [No Abstract] [Full Text] [Related]
11. Oxaliplatin in non-seminomatous germ-cell tumors. Fizazi K; Culine S; Chen I Ann Oncol; 2004 Aug; 15(8):1295. PubMed ID: 15277272 [No Abstract] [Full Text] [Related]
12. A phase I-II trial of intensive chemotherapy (CT) with autologous bone-marrow transplantation (ABMT) in metastatic malignant germ cell tumors of the testis (NSGCTT). Droz JP; Pico JL; Hayat M; Kamioner D; Gouyette A; Beaujean F Prog Clin Biol Res; 1985; 203():449-50. PubMed ID: 3008182 [No Abstract] [Full Text] [Related]
13. Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT. Einhorn LH; Brames MJ; Heinrich MC; Corless CL; Madani A Am J Clin Oncol; 2006 Feb; 29(1):12-3. PubMed ID: 16462496 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of iproplatin (CHIP) in patients with cisplatin-refractory germ cell tumors; the need for alternative strategies in the investigation of new agents in GCT. Murphy BA; Motzer RJ; Bosl GJ Invest New Drugs; 1992 Nov; 10(4):327-30. PubMed ID: 1336770 [TBL] [Abstract][Full Text] [Related]
15. Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies. Beer TM; Tangen CM; Nichols CR; Margolin KA; Dreicer R; Stephenson WT; Quinn DI; Raghavan D; Crawford ED Cancer; 2006 Jun; 106(12):2624-9. PubMed ID: 16688776 [TBL] [Abstract][Full Text] [Related]